AIMS: The F-actin-binding protein Drebrin inhibits smooth muscle cell (SMC) migration, proliferation, and pro-inflammatory signalling. Therefore, we tested the hypothesis that Drebrin constrains atherosclerosis. METHODS AND RESULTS: SM22-Cre+/Dbnflox/flox/Ldlr-/- (SMC-Dbn-/-/Ldlr-/-) and control mice (SM22-Cre+/Ldlr-/-, Dbnflox/flox/Ldlr-/-, and Ldlr-/-) were fed a western diet for 14-20 weeks. Brachiocephalic arteries of SMC-Dbn -/-/Ldlr-/- mice exhibited 1.5- or 1.8-fold greater cross-sectional lesion area than control mice at 14 or 20 weeks, respectively. Aortic atherosclerotic lesion surface area was 1.2-fold greater in SMC-Dbn-/-/Ldlr-/- mice. SMC-Dbn-/-/Ldlr-/- lesions comprised necrotic cores that were two-fold greater in size than those of control mice. Consistent with their bigger necrotic core size, lesions in SMC-Dbn-/- arteries also showed more transdifferentiation of SMCs to macrophage-like cells: 1.5- to 2.5-fold greater, assessed with BODIPY or with CD68, respectively. In vitro data were concordant: Dbn-/- SMCs had 1.7-fold higher levels of KLF4 and transdifferentiated to macrophage-like cells more readily than Dbnflox/flox SMCs upon cholesterol loading, as evidenced by greater up-regulation of CD68 and galectin-3. Adenovirally mediated Drebrin rescue produced equivalent levels of macrophage-like transdifferentiation in Dbn-/- and Dbnflox/flox SMCs. During early atherogenesis, SMC-Dbn-/-/Ldlr-/- aortas demonstrated 1.6-fold higher levels of reactive oxygen species than control mouse aortas. The 1.8-fold higher levels of Nox1 in Dbn-/- SMCs were reduced to WT levels with KLF4 silencing. Inhibition of Nox1 chemically or with siRNA produced equivalent levels of macrophage-like transdifferentiation in Dbn-/- and Dbnflox/flox SMCs. CONCLUSION: We conclude that SMC Drebrin limits atherosclerosis by constraining SMC Nox1 activity and SMC transdifferentiation to macrophage-like cells. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The F-actin-binding protein Drebrin inhibits smooth muscle cell (SMC) migration, proliferation, and pro-inflammatory signalling. Therefore, we tested the hypothesis that Drebrin constrains atherosclerosis. METHODS AND RESULTS: SM22-Cre+/Dbnflox/flox/Ldlr-/- (SMC-Dbn-/-/Ldlr-/-) and control mice (SM22-Cre+/Ldlr-/-, Dbnflox/flox/Ldlr-/-, and Ldlr-/-) were fed a western diet for 14-20 weeks. Brachiocephalic arteries of SMC-Dbn -/-/Ldlr-/- mice exhibited 1.5- or 1.8-fold greater cross-sectional lesion area than control mice at 14 or 20 weeks, respectively. Aortic atherosclerotic lesion surface area was 1.2-fold greater in SMC-Dbn-/-/Ldlr-/- mice. SMC-Dbn-/-/Ldlr-/- lesions comprised necrotic cores that were two-fold greater in size than those of control mice. Consistent with their bigger necrotic core size, lesions in SMC-Dbn-/- arteries also showed more transdifferentiation of SMCs to macrophage-like cells: 1.5- to 2.5-fold greater, assessed with BODIPY or with CD68, respectively. In vitro data were concordant: Dbn-/- SMCs had 1.7-fold higher levels of KLF4 and transdifferentiated to macrophage-like cells more readily than Dbnflox/flox SMCs upon cholesterol loading, as evidenced by greater up-regulation of CD68 and galectin-3. Adenovirally mediated Drebrin rescue produced equivalent levels of macrophage-like transdifferentiation in Dbn-/- and Dbnflox/flox SMCs. During early atherogenesis, SMC-Dbn-/-/Ldlr-/- aortas demonstrated 1.6-fold higher levels of reactive oxygen species than control mouse aortas. The 1.8-fold higher levels of Nox1 in Dbn-/- SMCs were reduced to WT levels with KLF4 silencing. Inhibition of Nox1 chemically or with siRNA produced equivalent levels of macrophage-like transdifferentiation in Dbn-/- and Dbnflox/flox SMCs. CONCLUSION: We conclude that SMC Drebrin limits atherosclerosis by constraining SMC Nox1 activity and SMC transdifferentiation to macrophage-like cells. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Francis J Miller; Mohammed Filali; Gina J Huss; Bojana Stanic; Ali Chamseddine; Thomas J Barna; Fred S Lamb Journal: Circ Res Date: 2007-08-02 Impact factor: 17.367
Authors: Dorien M Schrijvers; Guido R Y De Meyer; Mark M Kockx; Arnold G Herman; Wim Martinet Journal: Arterioscler Thromb Vasc Biol Date: 2005-04-14 Impact factor: 8.311
Authors: Jonathan A Stiber; Jiao-Hui Wu; Lisheng Zhang; Igor Nepliouev; Zhu-Shan Zhang; Victoria G Bryson; Leigh Brian; Rex C Bentley; Phillip R Gordon-Weeks; Paul B Rosenberg; Neil J Freedman Journal: Arterioscler Thromb Vasc Biol Date: 2016-03-24 Impact factor: 8.311
Authors: Bin Li; Siyuan Ding; Ningguo Feng; Nancie Mooney; Yaw Shin Ooi; Lili Ren; Jonathan Diep; Marcus R Kelly; Linda L Yasukawa; John T Patton; Hiroyuki Yamazaki; Tomoaki Shirao; Peter K Jackson; Harry B Greenberg Journal: Proc Natl Acad Sci U S A Date: 2017-04-17 Impact factor: 11.205
Authors: Yan Liu; Sanjay Sinha; Oliver G McDonald; Yueting Shang; Mark H Hoofnagle; Gary K Owens Journal: J Biol Chem Date: 2004-12-28 Impact factor: 5.157
Authors: Francis J Miller; Xi Chu; Bojana Stanic; Xin Tian; Ram V Sharma; Robin L Davisson; Fred S Lamb Journal: Antioxid Redox Signal Date: 2010-03-01 Impact factor: 8.401
Authors: Lisheng Zhang; Jiao-Hui Wu; Tai-Qin Huang; Igor Nepliouev; Leigh Brian; Zhushan Zhang; Virginia Wertman; Nathan P Rudemiller; Timothy J McMahon; Sudha K Shenoy; Francis J Miller; Steven D Crowley; Neil J Freedman; Jonathan A Stiber Journal: Cardiovasc Res Date: 2018-11-01 Impact factor: 10.787